✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹131 Cr.
P/E
16.35
  • Sotac Pharmaceutical
  • Denis Chem Lab
  • Bal Pharma

FAQs on Sotac Pharmaceuticals Ltd. Shareprice

Sotac Pharmaceutical has given better returns compared to its competitors.
Sotac Pharmaceutical has grown at ~1.82% over the last 2yrs while peers have grown at a median rate of -3.91%

Sotac Pharmaceutical is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Sotac Pharmaceutical is 17.13, while 3 year average PE is 41.06.
Also latest EV/EBITDA of Sotac Pharmaceutical is 19.39 while 3yr average is 18.68.

Growth Table

  • Sotac Pharmaceuticals Ltd.
  • Denis Chem Lab
  • Bal Pharma

Balance Sheet

  • Sotac Pharmaceuticals Ltd.
  • Denis Chem Lab
  • Bal Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Sotac Pharmaceuticals Ltd.
  • Denis Chem Lab
  • Bal Pharma

Cash Flow

  • Sotac Pharmaceuticals Ltd.
  • Denis Chem Lab
  • Bal Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Sotac Pharmaceuticals Ltd.
  • Denis Chem Lab
  • Bal Pharma

Quarterly Results

  • Sotac Pharmaceuticals Ltd.
  • Denis Chem Lab
  • Bal Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Sotac Pharmaceuticals Ltd. Financials

Balance sheet of Sotac Pharmaceutical is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Sotac Pharmaceutical is increasing.
Latest net debt of Sotac Pharmaceutical is ₹42.13 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹18.43 Crs.

The profit is oscillating.
The profit of Sotac Pharmaceutical is ₹3.78 Crs for TTM, ₹4.28 Crs for Mar 2024 and ₹2.88 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sotac Pharmaceutical latest dividend payout ratio is 15.98% and 3yr average dividend payout ratio is 15.98%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech